148 related articles for article (PubMed ID: 35865938)
41. Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.
Khandelwal P; Teusink-Cross A; Davies SM; Nelson AS; Dandoy CE; El-Bietar J; Marsh RA; Kumar AR; Grimley MS; Jodele S; Myers KC
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1122-1127. PubMed ID: 28344057
[TBL] [Abstract][Full Text] [Related]
42. Detection of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation. An Official American Thoracic Society Clinical Practice Guideline.
Shanthikumar S; Document S; Gower WA; Srinivasan S; Rayment JH; Robinson PD; Bracken J; Stone A; Das S; Barochia A; Charbek E; Tamae-Kakazu M; Reardon EE; Abts M; Blinman T; Calvo C; Cheng PC; Cole TS; Cooke KR; Davies SM; De A; Gross J; Mechinaud F; Sheshadri A; Siddaiah R; Teusink-Cross A; Towe CT; Walkup LL; Yanik GA; Bergeron A; Casey A; Deterding RR; Liptzin DR; Schultz KR; Iyer NP; Goldfarb S
Am J Respir Crit Care Med; 2024 Jun; ():. PubMed ID: 38889365
[TBL] [Abstract][Full Text] [Related]
43. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature.
Soubani AO; Kingah P; Alshabani K; Muma G; Haq A
Clin Transplant; 2014 Jul; 28(7):776-82. PubMed ID: 24754643
[TBL] [Abstract][Full Text] [Related]
44. Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation.
Gao F; Chen J; Wei D; Wu B; Zhou M
Front Med; 2018 Apr; 12(2):224-228. PubMed ID: 28752350
[TBL] [Abstract][Full Text] [Related]
45. Ruxolitinib in children with steroid-refractory acute graft-versus-host disease: A retrospective multicenter study of the pediatric group of SFGM-TC.
Laisne L; Neven B; Dalle JH; Galambrun C; Esvan M; Renard C; Rialland F; Sirvent A; Gandemer V;
Pediatr Blood Cancer; 2020 Sep; 67(9):e28233. PubMed ID: 32614145
[TBL] [Abstract][Full Text] [Related]
46. Updated prevalence, predictors and treatment outcomes for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
Pham J; Rangaswamy J; Avery S; Borg B; Martin C; Munsif M; Lin T; Dabscheck E
Respir Med; 2021 Feb; 177():106286. PubMed ID: 33383436
[TBL] [Abstract][Full Text] [Related]
47. [Mesenchymal Stem Cells Combined with Budesonide, Almeterol and Azithromycin for the Treatment of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation].
Cao XP; Han DM; Wang ZD; Zheng XL; Ding L; Yan HM; Xue M; Zhu L; Liu J; Guo ZK; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):173-7. PubMed ID: 26913416
[TBL] [Abstract][Full Text] [Related]
48. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
Bacigalupo A; Chien J; Barisione G; Pavletic S
Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
[TBL] [Abstract][Full Text] [Related]
49. Ruxolitinib add-on in corticosteroid-refractory graft-
Dang SH; Liu Q; Xie R; Shen N; Zhou S; Shi W; Liu W; Zou P; You Y; Zhong ZD
World J Clin Cases; 2020 Mar; 8(6):1065-1073. PubMed ID: 32258077
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of high-dose budesonide/formoterol in patients with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant.
Kim KH; Lee J; Kim HJ; Lee S; Kim YJ; Lee JH; Rhee CK
J Thorac Dis; 2020 Aug; 12(8):4183-4195. PubMed ID: 32944330
[TBL] [Abstract][Full Text] [Related]
51. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M;
Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210
[TBL] [Abstract][Full Text] [Related]
52. Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.
Modi B; Hernandez-Henderson M; Yang D; Klein J; Dadwal S; Kopp E; Huelsman K; Mokhtari S; Ali H; Malki MMA; Spielberger R; Salhotra A; Zain J; Cotliar J; Parker P; Forman S; Nakamura R
Biol Blood Marrow Transplant; 2019 Feb; 25(2):265-269. PubMed ID: 30201397
[TBL] [Abstract][Full Text] [Related]
53. Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients.
Wei C; Zhang X; Liang D; Yang J; Du J; Yue C; Deng L
Drug Des Devel Ther; 2021; 15():4875-4883. PubMed ID: 34880598
[TBL] [Abstract][Full Text] [Related]
54. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
Abedin S; Yanik GA; Braun T; Pawarode A; Magenau J; Goldstein SC; Levine JE; Kitko CL; Couriel DR
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1127-31. PubMed ID: 25687798
[TBL] [Abstract][Full Text] [Related]
55. Cause of pleuroparenchymal fibroelastosis following allogeneic hematopoietic stem cell transplantation.
Higo H; Miyahara N; Taniguchi A; Maeda Y; Kiura K
Respir Investig; 2019 Jul; 57(4):321-324. PubMed ID: 31080050
[TBL] [Abstract][Full Text] [Related]
56. Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation.
Zhao Y; Shi J; Luo Y; Gao F; Tan Y; Lai X; Yu J; Wei G; Huang H
Biol Blood Marrow Transplant; 2020 May; 26(5):e128-e133. PubMed ID: 31982545
[TBL] [Abstract][Full Text] [Related]
57. Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease.
Algeri M; Becilli M; Locatelli F
Expert Rev Clin Immunol; 2023; 19(11):1299-1313. PubMed ID: 37606511
[TBL] [Abstract][Full Text] [Related]
58. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
[TBL] [Abstract][Full Text] [Related]
59. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
[TBL] [Abstract][Full Text] [Related]
60. [Kinetics of MDSC in Patients Treated Steroids-Ruxolitinib as the First Line Therapy for aGVHD].
Yang JJ; Peng B; Fang S; Wei Y; Wang H; Zhao YX; Qian K; Wen YN; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):276-285. PubMed ID: 35123640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
